Proceeds from issuance of common stock from direct offering, net of underwriting discounts, commissions, and offering expenses of 511,448 in 2026 and 112,922 in 2025
2,688,552
-
1,800,000
6,473,180
Proceeds from exercise of warrants
-
-
285
3,255,166
Proceeds from issuance of convertible preferred stock
-
-
0
990,000
Payment of offering costs for financing activities
-
-
353,480
1,418,459
(payments) proceeds from loans payable
-
-
-45,375
-
Payment on loans payable
46,109
29,544
-
-101,156
Principal repayments on finance leases
20,016
77,174
73,074
58,031
Net cash provided by financing activities
2,622,427
-118,513
1,340,151
9,343,012
Net decrease in cash and cash equivalents
-668,647
-3,351,416
-1,219,413
6,866,360
Cash and cash equivalents at beginning of period
3,098,366
6,449,782
7,669,195
1,105,291
Cash and cash equivalents at end of period
2,429,719
3,098,366
6,449,782
7,669,195
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.